Latest news and stories about oncology in health in Portugal for expats and residents.
A research team led by Paula Videira at NOVA University Lisbon has developed a breakthrough antibody that precisely differentiates cancer cells from healthy tissue, earning the scientist a nomination for the European Inventor Award.
Andrea De Censi, a researcher at the Champalimaud Foundation, argues that Portugal is 50 years behind in oncology prevention compared to cardiovascular medicine, citing the example of patients with high cholesterol who are diagnosed and treated early. The remarks were made at the CNN Portugal Health Innovation Summit.
RTP journalist Paula Rebelo was awarded the Second Journalism Prize by the Portuguese League Against Cancer.
The new room will allow for an increase in capacity and improve the conditions for preparing cytotoxic drugs used in cancer treatments.
Aveiro Hospital innovates in oncological procedures.
Oncologist Patrícia Pereira, from the Portuguese Institute of Oncology, details the characteristics of the experimental treatment, highlighting that it is not a “preventive vaccine” for all patients, but is applicable to those who have already had melanoma and can, in this way, reduce the possibility of the disease returning.
Cooperation between the two institutions will be based on four fundamental strategic pillars
Home News Health Unit in Portugal strengthens liver cancer treatment Health Unit in Portugal strengthens liver cancer treatment The Local Health Unit of Trás-os-Montes and Alto Douro ( ULSTMAD) has strengthened its therapeutic response for patients with liver cancer through a “minimally invasive”
Study shows that the activation of these receptors could increase the effectiveness of temozolomide, the main drug used in the treatment of glioblastoma
It was an emotionally charged moment at the world's largest oncology conference in Chicago. The drug, announced by scientist Brian M. Wolpin, manages to double the average life expectancy of patients compared to traditional chemotherapy. Experts are already speaking of the beginning of a new era in the fight against one of the deadliest tumours.
Home Health HPA Algarve Oncology Meetings 2026 Algarve Oncology Meetings 2026 The Algarve Oncology Meetings 2026, held on 22 and 23 May at the Hotel Eva Senses in Faro, concluded with an extremely positive outcome, reinforcing their position as one of the region’s leading scientific forums for de
These and other measures were recommended to better treat gynaecological cancer, which was at the centre of this afternoon's debates with doctors and patient associations. In recent years, Expresso, with the support of GSK, has given a voice to specialists and people with rare diseases through the project “Forgotten Diseases, Unique People”.
A centre in Portugal is part of one of the world's largest clinical trial consortia for oncology research. New ways of fighting cancer are being tested, offering a new opportunity for patients who have not responded to other treatments.
Over the last three years, Infarmed has authorised 591 new clinical trials, one-third of which are in the field of cancer.
'A Montanha' (The Mountain) emerged from an idea by two clinicians at the IPO in Porto.
Tumour DNA fragments can help predict the return of the disease, especially when samples are collected after pre-surgical treatments.
The selected projects cover the areas of HIV, chronic viral hepatitis, breast cancer, and B-cell non-Hodgkin lymphoma. In total, 47 applications were received from various entities.
This is the seventh edition of the IPO Porto Solidarity Gala. The event will bring together several Portuguese music artists to support oncology research and also marks the institute's 52nd anniversary.
The protocol was advocated by the Portuguese Institute of Oncology, which says that 'if a lesion is identified at an early stage, it can be treated.' Portugal has a high incidence of cases.
The Minister of the Presidency, António Leitão Amaro, said today in Leiria that Santo André Hospital in the city has made four orthopaedic operating theatres available and has ensured the continuity of oncology services.
The recommended medicines target several therapeutic areas, including oncology, cardiovascular, dermatology, endocrinology, gastroenterology, infections, metabolism and vaccines.
Home News Portugal invests €11. 6 million in medical equipment Portugal invests €11. 6 million in medical equipment The Portuguese Oncology Institute of Coimbra will invest €11.
Luís Arnaut, a professor at FCTUC (Faculty of Science and Technology, University of Coimbra), explains more about a molecule developed by a group of researchers at the University of Coimbra that makes the process of combating cancer cells more effective.
